These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34240505)

  • 1. cagA+ Helicobacter pylori infection and N-nitrosodimethylamine and cholangiocarcinoma.
    Mungmunpuntipantip R; Wiwanitkit V
    Helicobacter; 2021 Oct; 26(5):e12834. PubMed ID: 34240505
    [No Abstract]   [Full Text] [Related]  

  • 2. CagA
    Dangtakot R; Intuyod K; Chamgramol Y; Pairojkul C; Pinlaor S; Jantawong C; Pongking T; Haonon O; Ma N; Pinlaor P
    Helicobacter; 2021 Aug; 26(4):e12817. PubMed ID: 34031944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori in Thai patients with cholangiocarcinoma and its association with biliary inflammation and proliferation.
    Boonyanugomol W; Chomvarin C; Sripa B; Bhudhisawasdi V; Khuntikeo N; Hahnvajanawong C; Chamsuwan A
    HPB (Oxford); 2012 Mar; 14(3):177-84. PubMed ID: 22321036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent advanced periductal fibrosis is associated with cagA-positive Helicobacter pylori infection in post-praziquantel treatment of opisthorchiasis.
    Phung HTT; Deenonpoe R; Suttiprapa S; Mairiang E; Edwards SW; Sripa B
    Helicobacter; 2022 Aug; 27(4):e12897. PubMed ID: 35527695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of Helicobacter pylori virulent-associated genes in hepatobiliary patients.
    Boonyanugomol W; Chomvarin C; Sripa B; Chau-In S; Pugkhem A; Namwat W; Wongboot W; Khampoosa B
    HPB (Oxford); 2012 Nov; 14(11):754-63. PubMed ID: 23043664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effects of cagA+ Helicobacter pylori co-infected with Opisthorchis viverrini on hepatobiliary pathology in hamsters.
    Suyapoh W; Tangkawattana S; Suttiprapa S; Punyapornwithaya V; Tangkawattana P; Sripa B
    Acta Trop; 2021 Jan; 213():105740. PubMed ID: 33159904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opisthorchiasis, Helicobacter pylori infection, cholangiocarcinoma, and L-fucose: Interrelationship.
    Mungmunpuntipantip R; Wiwanitkit V
    J Cancer Res Ther; 2024 Jan; 20(1):502-503. PubMed ID: 38261443
    [No Abstract]   [Full Text] [Related]  

  • 8. Co-infections with liver fluke and Helicobacter species: A paradigm change in pathogenesis of opisthorchiasis and cholangiocarcinoma?
    Sripa B; Deenonpoe R; Brindley PJ
    Parasitol Int; 2017 Aug; 66(4):383-389. PubMed ID: 27919744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter species infection may be associated with cholangiocarcinoma: a meta-analysis.
    Xiao M; Gao Y; Wang Y
    Int J Clin Pract; 2014 Feb; 68(2):262-70. PubMed ID: 24373128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiota studies in the bile duct strongly suggest a role for Helicobacter pylori in extrahepatic cholangiocarcinoma.
    Avilés-Jiménez F; Guitron A; Segura-López F; Méndez-Tenorio A; Iwai S; Hernández-Guerrero A; Torres J
    Clin Microbiol Infect; 2016 Feb; 22(2):178.e11-178.e22. PubMed ID: 26493848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori cagA and vacA cytotoxin genes in Changsha, China.
    Yakoob J; Fan XG; Peng XN; Hu GL; Zhang Z
    Br J Biomed Sci; 2002; 59(3):150-3. PubMed ID: 12371056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CagA and the outcome of Helicobacter pylori infection.
    Blaser MJ; Crabtree JE
    Am J Clin Pathol; 1996 Nov; 106(5):565-7. PubMed ID: 8929462
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk for gastric lymphoma in persons with CagA+ and CagA- Helicobacter pylori infection.
    Witherell HL; Hansen S; Jellum E; Orentreich N; Vogelman JH; Parsonnet J
    J Infect Dis; 1997 Dec; 176(6):1641-4. PubMed ID: 9395383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advances in CagA protein and CagAmediated pathogenesis of Helicobacter pylori-A review].
    Wan X; Liu C
    Wei Sheng Wu Xue Bao; 2016 Dec; 56(12):1821-30. PubMed ID: 29741846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Helicobacter species in the liver of patients with and without primary liver carcinoma.
    Avenaud P; Marais A; Monteiro L; Le Bail B; Bioulac Sage P; Balabaud C; Mégraud F
    Cancer; 2000 Oct; 89(7):1431-9. PubMed ID: 11013355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism in the Helicobacter pylori CagA and VacA toxins and disease.
    Bridge DR; Merrell DS
    Gut Microbes; 2013; 4(2):101-17. PubMed ID: 23380646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between TNF-alpha promoter polymorphism and Helicobacter pylori cagA subtype infection.
    Yea SS; Yang YI; Jang WH; Lee YJ; Bae HS; Paik KH
    J Clin Pathol; 2001 Sep; 54(9):703-6. PubMed ID: 11533078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori CagA as a potential bacterial oncoprotein in gastric carcinogenesis.
    Hatakeyama M
    Pathol Biol (Paris); 2003 Sep; 51(7):393-4. PubMed ID: 12948757
    [No Abstract]   [Full Text] [Related]  

  • 19. Can bacterial virulence factors predict antibiotic resistant
    Brennan DE; Dowd C; O'Morain C; McNamara D; Smith SM
    World J Gastroenterol; 2018 Mar; 24(9):971-981. PubMed ID: 29531461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H. pylori and cagA: relationships with gastric cancer, duodenal ulcer, and reflux esophagitis and its complications.
    Graham DY; Yamaoka Y
    Helicobacter; 1998 Sep; 3(3):145-51. PubMed ID: 9731983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.